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Abstract
Amyloid formation and mitochondrial dysfunction are characteristics of type 2 diabetes. The
major peptide constituent of the amyloid deposits in type 2 diabetes is islet amyloid polypep-
tide (IAPP). In this study, we found that pitrilysin, a zinc metallopeptidase of the inverzincin
family, degrades monomeric, but not oligomeric, islet amyloid polypeptide in vitro. In insuli-
noma cells when pitrilysin expression was decreased to 5% of normal levels, there was a
60% increase in islet amyloid polypeptide-induced apoptosis. In contrast, overexpression of
pitrilysin protects insulinoma cells from human islet amyloid polypeptide-induced apoptosis.
Since pitrilysin is a mitochondrial protein, we used immunofluorescence staining of pancre-
ases from human IAPP transgenic mice and Western blot analysis of IAPP in isolated mito-
chondria from insulinoma cells to provide evidence for a putative intramitochondrial pool of
IAPP. These results suggest that pitrilysin regulates islet amyloid polypeptide in beta cells
and suggest the presence of an intramitochondrial pool of islet amyloid polypeptide involved
in beta-cell apoptosis.
Introduction
Type 2 diabetes is characterized by a loss of beta cell mass and function, along with the deposi-
tion of amyloid in pancreatic islets [1–4]. The main constituent of islet amyloid is islet amyloid
polypeptide (IAPP, amylin). Human IAPP (hIAPP), but not rodent IAPP (rIAPP), forms olig-
omers and fibrils leading to the amyloid deposits associated with type 2 diabetes [3]. What
causes beta-cell death when hIAPP aggregates is still debated [3, 5], however evidence suggests
hIAPP oligomers as the toxic species. hIAPP oligomers are found within beta-cells in hIAPP
transgenic mice [6, 7] where they disrupt membranes [8]. As a consequence of endoplasmic
reticulum membrane disruption, hIAPP oligomers induce apoptosis through endoplasmic reti-
culumstress [9, 10].
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Similarities exist between the relationships of hIAPP to type 2 diabetes and human amyloid
beta peptide (hAβ) to Alzheimer’s disease [11]. In both disorders toxic peptide oligomers are
formed and mitochondrial dysfunction plays an important role [12–15]. In Alzheimer's dis-
ease, mitochondria are a direct site of Aβ accumulation [16, 17] with Aβ transported into mito-
chondria through translocases [18]. In type 2 diabetes mitochondrial dysfunction is associated
with insulin resistance in peripheral tissues [13, 14] and with pancreatic beta-cell dysfunction
[14, 15]. Exogenous hIAPP induces mitochondrial dysfunction in INS-1E cells [19], however
the mechanism is not fully understood.
The mitochondrial peptidase, pitrilysin, cleaves mitochondrial Aβ [20], however the ability
of pitrilysin to cleave IAPP has not been investigated until now. We have studied the cleavage
of IAPP by pitrilysin and provide evidence that pitrilysin is likely involved in the regulation of
IAPP in vivo.
Materials and Methods
Animals
hIAPP transgenic mice (FVB/N-Tg(Ins2-IAPP)RHFSoel/J) (Jackson laboratory, Bar Harbor,
Maine, USA) accumulate amyloid in the pancreas and develops hyperglycemia [6, 21]. Pan-
creas sections from homozygous 3-month-old male mice were used in this study.
Human islets were purchased from Prodo Laboratories (Irvine, CA, USA).
Materials
Cell culture reagents were from Invitrogen (Carlsbad, CA, USA). hIAPP was from Anaspec
(Fremont, CA, USA). Adenoviruses (Adv) expressing green fluorescent protein (GFP), pre-
pro-rIAPP-GFP, and prepro-hIAPP-GFP were generously provided by Dr. Christopher
Rhodes (University of Chicago, Chicago, IL, USA) and expanded as described [22]. For immu-
noblotting, immunocytochemistry and immunoprecipitation the following antibodies were
used: rabbit anti-amyloid oligomer A11, (Millipore, Billerica, MA, USA), mouse anti-hIAPP
(Abcam, Cambridge, MA, USA), rabbit anti-hIAPP (Bachem, San Carols, CA, USA), monoclo-
nal anti-hIAPP antibody (E-5, Santa Cruz Biotechnology, Santa Cruz, USA), rabbit polyclonal
anti-human/rat IAPP (Bachem-Peninsula Laboratories, San Carlos, CA, USA), mouse anti-
insulin (Cell Signaling, Danvers, MA, USA), rabbit anti-pitrilysin (Pierce, Rockford, IL, USA),
mouse anti-VDAC1 (Millipore, Billerica, MA, USA), rabbit anti-cleaved caspase-3 (Cell Signal-
ing Technology, Danvers, MA, USA), mouse anti-β-actin (EMD Chemicals, Gibbstown, NJ,
USA), and mouse anti-Flag (M2, Sigma). Rabbit anti-mitochondrial malate dehydrogenase
(mMDH) antibody was generously provided by Dr. Arnold W. Strauss (Vanderbilt University,
Nashville, TN, USA). Rabbit anti-cytosolic thiolase antibody was generously provided by Dr.
Sidney W. Whiteheart (University of Kentucky, Lexington, KY, USA). Rabbit anti-human
pitrilysin [23] and rabbit anti-insulin-degrading enzyme (IDE) [24] were as described.
Production and purification of recombinant pitrilysin
Pitrilysin was produced in Sf9 cells (ATCC, Manassas, VA, USA) and purified as described.
[23]. The purity of recombinant pitrilysin is greater than 97% as judged from Coomassie blue
stained SDS-PAGE gels using NIH ImageJ software [25] (S1 Fig).
In vitro cleavage of hIAPP by pitrilysin
Monomeric hIAPP (20 μM) was incubated with 40 nM pitrilysin in 50 mM Tris/HCl buffer
(pH 7.4) containing 200 mMNaCl at 37°C for various times and analyzed by reverse phase
Regulation of Islet Amyloid Polypeptide by Pitrilysin in Beta-Cells
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HPLC [22, 23]. hIAPP and its cleavage products were collected manually and identified by
mass spectrometry.
In vitro cleavage of oligomeric hIAPP by pitrilysin
hIAPP was incubated at 37°C for 1 hr. with gentle shaking to induce hIAPP oligomerization.
To produce low molecular weight oligomers, hIAPP oligomerization was initiated in saline
solution at 37°C using 50 μM recombinant hIAPP and then incubated with myocytes for 2
hours at room temperature [26]. Similarly cardiac myocytes from hIAPP expressing rats (HIP
rats) contain amylin oligomers and thus both were used. Pitrilysin was added to oligomers and
incubated for 1 hour at 37°C. The reaction was then subjected to SDS-PAGE and Western blot-
ting with A11 antisera for large oligomer or with mouse anti-hIAPP for detection of monomers
and small oligomers. Adult cardiac myocytes were isolated from wild-type Sprague-Dawley
rats and from HIP rats as described [27].
Cell culture
The rat insulinoma cell line INS 832/13 was kindly provided by Dr. Christopher Newgard
(Duke University, Durham, NC, USA) and cultured as described [28, 29].
Immunocytochemistry and confocal microscopy
INS 832/13 cells were plated on coverslips and transfected with pcDNA3.1-pitrilysin-flag [23]
or pCMV6-XL5-prepro-hIAPP (Origene, Rockville, MD, USA) using lipofectamine 2000 (Invi-
trogen). Cells were fixed 48 hrs. post transfection with 4% paraformadehyde and used for
immunofluorescence staining. Pancreas samples from hIAPP transgenic mice were fixed with
10% formalin, embedded in paraffin, and sectioned at 5μm thickness. Sections were deparaffi-
nized followed by antigen unmasking with heat treatment. Cells or sections were permeabilized
with 0.1% Triton X-100, blocked with 10% normal goat serum and then incubated with the
appropriate antibody overnight at 4°C. Antibodies used were mouse anti-hIAPP (1:100), rabbit
anti-mitochondrial malate dehydrogenase (1:200), mouse anti-insulin (1:1000), mouse anti-
Flag (M2) (1:200), mouse anti-VDAC1 (1:100), or rabbit anti-pitrilysin (1:100). Cells or sec-
tions were then incubated with fluorescein isothiocyanate and/or Cy3-conjugated goat IgG
(1:100; Jackson ImmunoResearch, West Grove, PA, USA) and mounted in Vectashield (Vector
Laboratories, Burlingame, CA, USA). Confocal microscopy images were taken with a Nikon
A1 resonance scanning microscope (Nikon Instruments Inc., Melville, NY, USA) using a 40×
or 60× oil immersion objective and a 4× optical zoom. Colocalization of hIAPP with a mito-
chondrial marker was measured as described previously [30]. Briefly, the 2 channels of hIAPP
or insulin and mitochondrial MDH double staining were transformed into 8-bit grayscale
images and thresholded. The grayscale images for hIAPP/insulin and mMDH were then
merged, and the total pixels of hIAPP or insulin (X), mMDH (Y), and the merged images (Z)
were determined using Image J software. The percentage of hIAPP/Insulin that colocalized
with mMDH is defined as (X + Y–Z)/Y × 100.
Knockdown of pitrilysin and IDE production in INS 832/13 cells
GIPZ lentiviral shRNAmir vectors against rat pitrilysin (V3LMM_494519), rat IDE
(V3LHS_312518) and a non-silencing control (RHS4346) were from Open Biosystems (Hunts-
ville, AL, USA). These and other lentiviruses were produced according to the manufacturer’s
instructions. For selection of INS 832/13 stable cells in which the level of pitrilysin or IDE was
Regulation of Islet Amyloid Polypeptide by Pitrilysin in Beta-Cells
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knocked-down, cells were transduced with the appropriate lentivirus and then selected with
10 μg/ml puromycin. Knockdown of pitrilysin or IDE was confirmed by Western blot analysis.
Overexpression of pitrilysin
pcDNA3.1 vectors containing cDNAs of human pitrilysin (PITRM) [23] or its inactive E107Q
mutant [20] (PITRMx) tagged with a flag sequence were digested with BamHI/XhoI and sub-
cloned into the lentiviral vector pLenti6/V5 (Invitrogen). For selection of INS 832/13 stable
cells overexpressing pitrilysin or inactive pitrilysin, cells were transduced with the appropriate
lentivirus and then selected with 10 μg/ml blasticidin. Overexpression was confirmed by West-
ern blot analysis. Empty lentiviral vector was used as a control.
Cytotoxicity Studies
INS 832/13 cells were transduced with adenovirus expressing prepro-hIAPP-GFP at a multi-
plicity of infection (MOI) of 100 and cultured for 48 hours. Adenovirus expressing prepro-
rIAPP-GFP and GFP alone transduced at the same MOI were used as controls. Apoptosis was
determined by the amount of activated caspase-3 [10, 22, 31].
Isolation of mitochondria
Mitochondria were isolated from INS 832/13 cells by differential centrifugation followed by
Percoll purification [32].
Protease protection assay
Purified mitochondria were resuspended in mitochondria resuspension buffer (250 mMman-
nitol, 5 mMHEPES, pH 7.4 and 0.5 mM EGTA) at 0.4 mg total protein/ml and incubated for
30 min at 37°C with 10 μg/ml trypsin in the presence or absence of 0.1% Triton X-100. Trypsin
digestion was terminated by addition of 50 μg/ml trypsin inhibitor. SDS-PAGE loading buffer
was then added to the reaction followed by boiling and analysis by SDS-PAGE and immuno-
blotting as detailed below.
Western blot analysis
Protein concentration was determined using the BCA protein assay kit (Thermo Scientific,
Rockford, IL, USA). Cell lysates were separated on 4–12% Bis-Tris NuPAGE gels (Invitrogen)
and transferred to polyvinylidine difluoride membranes. For Western blotting of IAPP mem-
branes were boiled in PBS for 5 min before blocking. The following primary antibodies were
used: rabbit anti-amyloid oligomer (1:6,000), rabbit anti-cleaved caspase-3 (1:3,000), mouse
anti-β-actin (1:10,000), rabbit anti-IDE (1:5000), rabbit anti-pitrilysin (1:5000), goat anti-
calnexin (1:300), rabbit anti-cytosolic thiolase (1:6,000), rabbit anti-mitochondrial malate
dehydrogenase (1:12,000), or rabbit anti-hIAPP (1:3,000). Following incubation with the
appropriate primary antibody membranes were incubated with the corresponding horseradish
peroxidase-conjugated secondary antibody (Zymed Laboratories, San Francisco, CA, USA) fol-
lowed by SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific) and then
detected by luminescence. In some cases membranes were reprobed after stripping with strip-
ping buffer (GM Biosciences, Rockville, MD, USA).
Statistical analysis
Data are expressed as the mean ± SEM and compared using the Student’s t-test. Values are
considered to be statistically significant with a p<0.05.
Regulation of Islet Amyloid Polypeptide by Pitrilysin in Beta-Cells
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Ethics Statement
Animal protocols were approved by the University of Kentucky Animal Care and Use Com-
mittee and performed in accordance with University guidelines.
Results
Cleavage of IAPP by pitrilysin
As noted in the introduction, the zinc metallopeptidase pitrilysin has been shown to cleave
amyloid beta peptides [20]. Since IAPP (amylin) and amyloid beta peptides share many com-
mon features we tested whether IAPP is a substrate for pitrilysin. To demonstrate the cleavage
of monomeric IAPP by pitrilysin, recombinant human pitrilysin was incubated with human
IAPP (hIAPP) and the reaction followed by HPLC, Fig 1A. To confirm that the observed deg-
radation of hIAPP was mediated by pitrilysin, the purified enzyme was incubated with rabbit
anti-pitrilysin antibody followed by protein A/G Sepharose to immunodeplete the enzyme
from solution. As shown in Fig 1B, hIAPP degradation was abolished when pitrilysin was
immunodepleted with rabbit anti-pitrilysin antibody, but not with normal rabbit IgG or a
vehicle control, confirming that hIAPP degradation is indeed catalyzed by pitrilysin. Pitrilysin
also degrades monomeric rat IAPP (rIAPP), similar to monomeric hIAPP (data not shown).
Based on the crystal structure of pitrilysin [33] we would not expect the enzyme to degrade
IAPP oligomers since they could not easy fit into the enzyme active site. This was confirmed as
shown in Fig 2, by the inability of pitrilysin to reduce the amount of hIAPP oligomers of 12
kDa, 28 kDa, 36 kDa, or 40 kDa. These likely correspond to hIAPP trimers, heptamers, nono-
mers, and decamers, respectively. The same results were obtained using a different antibody
rabbit polyclonal, rabbit anti-IAPP T4157. Pitrilysin is also not able to degrade large hIAPP
large oligomers (Fig 2C). It is worth noting that the amount of pitrilysin used to test for the
degradation of hIAPP oligomers would have completely degraded monomeric hIAPP under
the reaction conditions employed. As expected rIAPP did not form large oligomers under our
experimental conditions. Thus pitrilysin degrades monomeric, but not oligomeric IAPP.
To identify the pitrilysin dependent peptide cleavage sites in hIAPP, reaction products were
first separated by HPLC (Fig 1A), manually collected and subjected to mass spectral analysis.
The identified degradation products are listed in S1 Table while a schematic representation
of the cleavage sites is shown in Fig 1C. Initial cleavage of hIAPP by pitrilysin (thick arrows,
Fig 1C) occurs between Phe15-Leu16, Gly24-Ala25 and Ala25-Ile26. Products were subsequently
cleaved at Arg11-Leu12, Leu12-Ala13, Ala13-Asn14 and Asn14-Phe15 (thin arrows, Fig 1C). The
degradation of hIAPP by pitrilysin resulted in the production of several 9–15 amino acid frag-
ments with the most abundant being the carboxy-terminal peptide 25-37-amide. Two of the
major cleavage sites (Gly24-Ala25 and Ala25-Ile26) are within the GAILS sequence believed to be
important for hIAPP aggregation and amyloidogenesis. Since five of the cleavage products
were clustered we assayed for carboxypeptidase activity in the pitrilysin preparation with hip-
puryl-L-phenylalanine as a general carboxypeptidase substrate [22, 34]. No such activity was
detected.
Comparison of the kinetic properties of pitrilysin to other IAPP degrading
peptidases
Having established IAPP as a substrate of pitrilysin, the kinetic properties of the reaction were
determined. The rate of hIAPP hydrolysis was determined by measuring the disappearance of
the substrate by HPLC, while kcat was determined based on the linear initial rate of hIAPP
hydrolysis at a saturating hIAPP concentration (20 μM) using a molecular mass of 117 kDa for
Regulation of Islet Amyloid Polypeptide by Pitrilysin in Beta-Cells
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pitrilysin. The KM for hIAPP was determined by using it as an alternate substrate inhibitor of
the hydrolysis of the fluorogenic peptide Abz-GGYRRGQ-EDDnp [23]. The kcat and KM values
of pitrilysin with hIAPP are 13.5 ± 0.1 min-1 and 0.38 ± 0.01 μM, respectively (Table 1). Since
pitrilysin cleaves amyloid β peptide 1–40 (Aβ1–40) [20, 35], we compared the kinetics with Aβ1–
40 to that of hIAPP and found that pitrilysin has a ~4 to 4.5 times higher cleavage rate and
higher affinity for hIAPP compared to Aβ1–40 (the kcat and KM value of pitrilysin with Aβ1–40 is
3.3 ± 0.1 min-1 and 1.7 ± 0.1 μM, respectively [23]. Thus the catalytic efficiency of pitrilysin
Fig 1. Degradation of monomeric hIAPP by pitrilysin. hIAPP (20 μM) was incubated with 40 nM pitrilysin
at 37°C with the reaction followed by HPLC. Peaks were collected and identified by mass spectral analysis. a.
HPLC chromatograms of hIAPP degradation by pitrilysin at the indicated times. * substrate impurity; # buffer
contamination; and a-m hIAPP cleavage products by pitrilysin. b. Immunodepletion of pitrilysin reduces
hIAPP degradation activity. Purified pitrilysin was incubated with a polyclonal rabbit anti-pitrilysin antibody,
normal rabbit IgG, or PBS followed by incubation with protein A/G-Sepharose beads. The beads were spun
down and the supernatants incubated with hIAPP. The hIAPP remaining was detected by HPLC as described
in Methods. c. Schematic of the cleavage sites on hIAPP. Thick arrows represent initial cleavages on hIAPP
by pitrilysin and thin arrows represent secondary cleavages.
doi:10.1371/journal.pone.0133263.g001
Regulation of Islet Amyloid Polypeptide by Pitrilysin in Beta-Cells
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towards hIAPP is 18 times higher than towards Aβ1–40 (kcat/KM = 35.5 and 1.94 min
-1μM-1 for
hIAPP and Aβ1–40, respectively) suggesting that hIAPP may be a physiologically relevant sub-
strate for pitrilysin.
Fig 2. Pitrilysin does not degrade oligomeric hIAPP in vitro. a. Oligomers of hIAPP were generated from hIAPP incubated with rat cardiac myocytes and
then incubated with pitrilysin (400 nM) at 37°C for 1 hr. Reactions were analyzed byWestern blot analysis using mouse monoclonal anti-human amylin
antibody E-5. b. Western blot of hIAPP oligomers generated from HIP rat cardiac myocytes incubated with pitrilysin. c. hIAPP were preincubated at 37°C to
induce oligomer formation and then incubated with or without 40 nM pitrilysin at 37°C for 1hr. Reactions were analyzed byWestern blots using rabbit anti-
IAPP that recognizes monomeric IAPP or rabbit anti-oligomer antibody A11. rIAPP (20 μM) was treated at the same condition as a negative control.
doi:10.1371/journal.pone.0133263.g002
Table 1. Comparison of enzymatic characters of pitrilysin and IDE towards different substrates.
Substrate Enzyme kcat (min
-1) KM (μM) kcat/KM (min
-1μM-1) Reference
hIAPP
Pitrilysin 13.5 ± 0.1 0.38 ± 0.01 35.5
IDE 294 ± 0.4 3.11 ± 0.20 94.5
Aβ40
Pitrilysin 3.3 ± 0.1 1.7 ± 0.1 1.95 [23]
IDE 221 ± 11 0.87 ± 0.10 250 [43]
Insulin
Pitrilysin 0.2 ± 0.0 54.5 ± 5.5 0.0037 [23]
IDE 0.56 ± 0.01 0.13 ± 0.02 4.3 [44]
The kcat value of pitrilysin towards hIAPP was determined based on the rate of hIAPP hydrolysis at a saturating concentration (20μM) and a molecular
mass of 117 kDa for pitrilysin.
The KM value of pitrilysin towards hIAPP was determined using hIAPP as an alternate substrate inhibitor of fluorogenic substrate Abz-
GGFYRRVGQ-EDDnp hydrolysis as described in Materials and Methods.
doi:10.1371/journal.pone.0133263.t001
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Insulin-degrading enzyme (IDE) has been shown to hydrolyze hIAPP [36]. We therefore
compared the enzymatic properties of these two enzymes in terms of hIAPP degradation. The
kcat and KM values for IDE with hIAPP were determined as above yielding values of 294 ± 0.4
min-1 and 3.11 ± 0.20 μM, respectively. Compared to IDE, the catalytic efficiency of pitrilysin
towards hIAPP is similar, exhibiting 40% of the catalytic efficiency of IDE (kat/KM = 35.5 and
94.5 min-1μM-1 for pitrilysin and IDE, respectively). Although IDE is a major insulin degrading
enzyme in vivo, pitrilysin was shown to be very inefficient in degrading insulin [23] (Table 1).
Thus relative to IDE, pitrilysin is a more specific IAPP degrading enzyme.
Pitrilysin expression in pancreatic islets
Pitrilysin has been shown to be located within the mitochondrial matrix [22,25]. We confirmed
the mitochondrial location of pitrilysin by demonstrating its colocalization with mMDH by
overexpression of pitrilysin in insulinoma cells INS 832/13 (Fig 3A). We also demonstrated a
mitochondrial location of pitrilysin in human islets by its colocalization with the mitochondrial
Fig 3. Pitrilysin expression in pancreatic beta-cells. a. INS 832/13 cells were transfected with pcDNA3.1-pitrilysin-flag. Forty-eight hrs. after transfection,
cells were fixed and stained for flag tagged pitrilysin and mitochondrial MDH. b. The mitochondrial location of pitrilysin in human islets evidenced by
colocalization of pitrilysin with the mitochondrial marker, voltage-dependent anion channel. c.Western blot analysis of pitrilysin in extracts of human islets
and subjected to Western blot analysis with polyclonal rabbit anti-pitrilysin antibody. Lane 1: human islet lysate (10 μg); Lane 2: 60 ng recombinant pitrilysin.
doi:10.1371/journal.pone.0133263.g003
Regulation of Islet Amyloid Polypeptide by Pitrilysin in Beta-Cells
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voltage-dependent anion channel 1 (Fig 3B). Western blot analysis of human islet extracts also
showed the presence of pitrilysin (Fig 3C).
Knockdown of pitrilysin in INS cells increases hIAPP-induced apoptosis
To determine whether endogenous pitrilysin regulates IAPP in cells we measured the effect of
pitrilysin on preventing hIAPP induced apoptosis. We used RNA interference (RNAi) to
decrease pitrilysin and then measured apoptosis produced by hIAPP. We introduced recombi-
nant hIAPP through an adenovirus vector [29] since the endogenous rIAPP does not oligomer-
ize and thus does not induce apoptosis. Cells were transduced with an shRNA specific to rat
pitrilysin (PITRMi) and selected with puromycin. Since inhibition of IDE also accelerates
hIAPP amyloid formation in insulinoma cells [36, 37], we used an shRNA specific to rat IDE
(IDEi) as a positive control and a nonsilencing shRNA (NSi) as a negative control. Fig 4A
shows that in INS832/13 cells pitrilysin levels were reduced ~95% by the shRNA, while IDE
levels were reduced by 80%. Cells were then transduced with adenovirus Adv- prepro-
hIAPP-GFP or Adv-prepro-rIAPP-GFP as a negative control, and apoptosis was evaluated by
measuring the cleavage of caspase-3.
When the pitrilysin-depleted cells expressed Adv-prepro-hIAPP-GFP, apoptosis signifi-
cantly increased relative to naïve cells, Fig 4B, but not in control cells. This finding confirms
hIAPP induced apoptosis. IDE knockdown (IDEi) also increased hIAPP-induced apoptosis as
expected. The nonsilencing control shRNA (NSi) did not affect hIAPP-induced apoptosis
(Fig 4B). Apoptosis was not induced by knockdown of pitrilysin or IDE in the absence of
Fig 4. Knockdown of pitrilysin in INS cells exacerbates hIAPP-induced apoptosis. Stably transfected INS 832/13 cells expressing an shRNA specific to
rat pitrilysin (PITRMi), rat IDE (IDEi) or non-silencing control shRNA (NSi) were selected using 10 μg/ml puromycin. Stable cells were then transduced with
Adv-prepro-hIAPP-GFP (MOI = 100) and apoptosis determined byWestern blot analysis of cleaved caspase-3. Band densities were analyzed using NIH
Image J software. The ratios of cleaved caspase-3 to actin intensities are indicated (n = 3). a. Pitrilysin in INS832/13 cells is reduced ~95% by lenti-PITRMi.
b. An approximate 60% increase (162.1 ± 13.2% of control, p<0.01) in apoptosis induced by hIAPP in pitrilysin shRNA treated cells compared to the lenti-NSi
control or parental INS 832/13 cells. shRNA treatment itself did not induce apoptosis.
doi:10.1371/journal.pone.0133263.g004
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hIAPP expression, nor by treatment with Adv-propro-rIAPP-GFP. These results strongly sup-
port a role for pitrilysin in the degradation of hIAPP in vivo.
Overexpression of pitrilysin protects INS cells from hIAPP-induced
apoptosis
To further examine the role of pitrilysin in regulating IAPP, we used lentivirus carrying human
pitrilysin to overexpress the enzyme. Lentivirus carrying an inactive E107Q mutant pitrilysin
(PITRMx) and empty lentiviral vector were used as negative controls. Fig 5A shows that lenti-
virus transformation increased pitrilysin levels by 80% for PITRMx and 60% for PITRM. The
cells with increased active pitrilysin were more resistant to Adv-prepro-hIAPP-GFP-induced
apoptosis compared to naïve cells, cells treated with empty lentiviral vector, as well as cells
treated with inactive pitrilysin (Fig 5B). As an additional control, cells treated with Adv-pre-
pro-ratIAPP-GFP did not exhibit significant apoptosis.
Intramitochondrial localization of IAPP in pancreatic beta-cells
Pitrilysin is known to be located within the mitochondrial matrix of cells [20, 23], and no stud-
ies have reported its location outside the mitochondrion. Therefore since pitrilysin is a mito-
chondrial protein and since pitrilysin protects against IAPP induced apoptosis, we questioned
whether there is a pool of IAPP inside mitochondria. This is the simplest explanation that
could account for pitrilysin’s action on preventing hIAPP induced apoptosis.
Fig 5. Overexpression of pitrilysin protects INS cells from hIAPP-induced toxicity. INS 832/13 cells were transduced with lentivirus carrying human
pitrilysin (PITRM), an inactive mutant (PITRMx), or empty lentiviral vector. Stable cell lines were isolated and then transduced with Adv-prepro-hIAPP-GFP.
Apoptosis was determined at 48 hrs. after transduction as in Fig 4 with the ratios of cleaved caspase-3 to actin intensities indicated (n = 3). a. Pitrilysin protein
levels were increased by 80% (PITRMx) and by 60% (PITRM) in the stable cell lines. b. An ~30% decrease (68.7 ± 10.3% of control, p<0.05) in apoptosis
induced by hIAPP was observed in pitrilysin overexpressing cells compared to empty lentiviral vector control, inactive pitrilysin (PITRMx) overexpressing
cells, or parental INS 832/13 cells. Treatment with Adv-prepro-rIAPP-GFP did not cause apoptosis.
doi:10.1371/journal.pone.0133263.g005
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To determine whether IAPP accumulates in the mitochondria of pancreatic beta-cells, the
pancreatic beta-cell line INS 832/13 [28] was transfected with plasmid pCMV6-XL5-prepro-
hIAPP producing hIAPP. Using double fluorescence staining, significant amounts of hIAPP
appeared to colocalize with the mMDH (Fig 6A). Similarly, the colocalization of hIAPP with
Fig 6. Mitochondrial localization of hIAPP. a. INS 832/13 cells were transfected with pCMV6-XL5-prepro-hIAPP. Forty-eight hrs. after transfection, cells
were fixed and stained for hIAPP (mouse anti-hIAPP) and mitochondrial malate dehydrogenase. b. hIAPP/mMDH and insulin/mMDH immunocytochemistry
performed on paraffin sections of pancreas from hIAPP transgenic mice. Staining was visualized with FITC conjugated goat anti-mouse and cy3 conjugated
goat anti-rabbit secondary antibodies. Confocal images were taken as described in Methods and merged with Adobe Photoshop software. Scale bar: 10μm.
Yellow color denotes colocalization.
doi:10.1371/journal.pone.0133263.g006
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mMDH was also indicated in pancreas sections of hIAPP transgenic mice, although the
resolution of the images were insufficient to distinguish the sub-organelle localization. In this
case the immunofluorescence corresponding to mitochondrial hIAPP was ~9% of total hIAPP
(Fig 6B, upper panel). In contrast and as a control, considerably less insulin appeared coloca-
lized with mMDH (~2% of total insulin immunoreactivity) representing background staining
(Fig 6, lower panel).
To provide additional evidence for a mitochondrial location of a pool of IAPP in pancreatic
beta-cells and eliminate any confounding effects of hIAPP oligomerization / assemblies on its
subcellular location, we examined the localization of endogenous rat IAPP in INS 832/13 cells
employing cell fractionation andWestern blot analysis [32]. Although hIAPP differs from
rIAPP in that the latter does not readily oligomerize, monomeric rIAPP should be similar to
monomeric hIAPP in terms of its subcellular localization. As expected the majority of the
detectable intracellular rIAPP localized to the microsomal fraction (Mi), mainly endoplasmic
reticulum (ER), however a fraction of rIAPP was found to be localized to mitochondria (Fig
7A). Although the majority of cellular IAPP appears to be located in the ER, the importance of
mitochondrial IAPP cannot be underestimated since as described below mitochondrial pitrily-
sin likely keeps its steady-state concentration low under normal conditions. Under pathological
conditions, the mitochondrial IAPP concentration could increase and be an important factor
in inducing mitochondrial dysfunction, similar to the role of mitochondrial amyloid β-peptide
in Alzheimer’s disease [38]. Importantly we were able to demonstrate that this mitochondrial
rIAPP is inside the mitochondria since it is protected from trypsin cleavage without prior mito-
chondrial membrane permeabilization (Fig 7B). Thus these data indicate a previously uniden-
tified mitochondrial pool of IAPP, which is analogous to the pool of Aβ localized inside
mitochondria in Alzheimer’s disease [16, 17].
Fig 7. Detection of IAPP in the mitochondrial fraction from INS cells. a. Protein components of subcellular fractions prepared from INS cells were
immunoblotted with anti-IAPP and antibodies to a cytosolic marker (cytosolic thiolase), an ERmarker (calnexin), and a mitochondrial markers (mitochondrial
malate dehydrogenase, mMDH). H: homogenate; C: cytosol; Mi: Microsomal fraction; Mc: crude mitochondrial fraction; Mp: purified mitochondrial fraction. b.
Purified mitochondria from INS cells were incubated with trypsin (10 μg/ml) in the presence or absence of Triton X-100 (0.01%) at 37°C for 30min. The
reactions were stopped with 50 μg/ml of trypsin inhibitor and subjected to SDS-PAGE andWestern blot analysis. IAPP in mitochondria is insensitive to
trypsin without prior Triton X-100 permeabilization suggesting an intramitochondrial location of IAPP.
doi:10.1371/journal.pone.0133263.g007
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Discussion
Pitrilysin was initially described as a metallopeptidase cleaving the opioid peptide leumorphin
[39] and later shown to cleave Aβ [20, 35]. We now show that pitrilysin is able to efficiently
cleave hIAPP. The overall degradation of hIAPP by pitrilysin results in the production of a
number of small peptides with the most abundant fragment being the COOH-terminal peptide
hIAPP25–37-amide. Cleavage of hIAPP by pitrilysin produces non-toxic products, likely due to
cleavages in the region of hIAPP known to be important for its oligomerization. Pitrilysin is
~20 times more efficient in cleaving hIAPP than Aβ. Thus, if pitrilysin is able to degrade Aβ in
vivo [20], it should also be able to degrade hIAPP in vivo. Our demonstration of pitrilysin in
human islets suggests pitrilysin plays a role in regulating IAPP levels in humans.
Given that knockdown of pitrilysin increased hIAPP-induced apoptosis and that overex-
pression of pitrilysin protects against hIAPP-induced apoptosis, this data strongly suggest that
pitrilysin contributes to the regulation of cellular IAPP levels. The fact that pitrilysin is known
to be a mitochondrial enzyme and the data presented here that suggests co-localization of a
fraction of IAPP with the mitochondrial marker mitochondrial malate dehydrogenase, these
findings raise the intriguing possibility that there exists an intramitochondrial pool of IAPP
which contributes to IAPP induced beta-cell death. Since pitrilysin degrades monomeric, but
not oligomeric IAPP, this putative mitochondrial pool of hIAPP must contain monomeric
IAPP. However, this mitochondrial hIAPP could aggregate to form toxic oligomers within the
mitochondrion. How monomeric IAPP is transported into mitochondria is currently unclear.
IAPP is synthesized in the ER as a precursor protein, which is then processed to its mature
form and secreted into the extracellular space [40]. hIAPP can be internalized by cells when
exogenously applied [41, 42], however extracellular monomeric IAPP is taken up by endocyto-
sis and trafficked into late endosomes or lysosomes from which it is cleared [41]. Extracellular
aggregates of hIAPP take on cell penetrating protein properties and can be translocated across
the cell membrane into the cytoplasm, where they can interact with the mitochondrial outer
membrane and induce mitochondrial dysfunction [41]. In addition, toxic oligomers of hIAPP
can be formed intracellularly within the secretory pathway where they disrupt membranes and
are released into the cytoplasm [7]. These secretory pathway derived oligomers can bind to and
disrupt the outer mitochondrial membranes producing mitochondrial dysfunction and apo-
ptosis. However, none of these IAPP pools would be substrates for pitrilysin, which resides
inside the mitochondrion. It is interesting to note that in the published EMmicrographs of
Gurlo et al. [7], one can see anti-IAPP staining in islet mitochondria, consistent with intramito-
chondrial IAPP.
Supporting Information
S1 Fig. Purity of recombinant pitrilysin analyzed by SDS-PAGE. Recombinant pitrilysin was
purified as described in the Methods section and analyzed by SDS-PAGE on a 10% polyacryl-
amide gel stained with Coomassie blue. The purity of recombinant pitrilysin is greater than
97%.
(TIF)
S1 Table. hIAPP cleavage fragments identified by Mass spectral analysis. 20μM hIAPP was
incubated with 40 nM recombinant pitrilysin at 37°C and the degradation of hIAPP was ana-
lyzed by HPLC. Peaks were collected manually and subjected to mass spectral analysis for iden-
tification. Peak designations are shown in Fig 1A.
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